跳至主要内容
临床试验/ACTRN12618000242224
ACTRN12618000242224终止未知

Prospective, contralateral, randomised, crossover dispensing clinical trialto compare the myopia progression rate between a myopia control contactlens and single vision contact lenses

Brien Holden Vision Institute0 个研究点目标入组 10 人开始时间: 2018年2月14日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 17 Years(—)
性别
All

入选标准

  • Aged between 6 years to 17 years (6 years and 17 years inclusive);
  • Spherical equivalent -0.75 D to -3.50 D with cylinder no more than -1.00 D; anisometropia of less than or equal to 0.75D
  • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent or have a parent / guardian who is able to give informed consent on the participant’s behalf.
  • Be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
  • Have ocular health findings considered to be normal” and which would not prevent the subject from safely wearing contact lenses;
  • Have vision correctable to at least 6/9.5 or better in each eye with study contact lenses.

排除标准

  • Participants enrolled in the trial must NOT have:
  • pre-existing ocular irritation that would preclude contact lens fitting;
  • any systemic or ocular condition or ocular injury that may preclude safe wearing of contact lenses;
  • undergone corneal refractive surgery;
  • Keratoconus
  • a known allergy to, or a history of intolerance to cyclopentolate or topical anaesthetics;
  • at baseline, astigmatism more than 1.00 D in either eye;
  • had strabismus and/or current ongoing amblyopia;
  • any ocular, systemic or other condition or disease with possible associations with myopia or affecting refractive development e.g. Marfan syndrome, retinopathy of prematurity;
  • current orthoptic treatment or vision training;
  • eye injury or surgery within 12 weeks immediately prior to enrolment for this trial;
  • undergone atropine treatment for myopia control;
  • worn bifocal or progressive addition spectacles or anti-myopia contact lenses previously;
  • worn orthokeratology lenses previously;
  • require anticholinergic medication for gastrointestinal or other conditions;
  • at baseline, be anisometropic by more than 0.75D;

研究者

发起方
Brien Holden Vision Institute

相似试验